A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Clinical trial NCT05508620 · UNKNOWN

Trial details

NCT number: NCT05508620
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumors

Start date: 2022-10-01
Primary completion: 2024-12-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.